Skip to search formSkip to main contentSkip to account menu

Gadopentetate Dimeglumine

Known as: Gadolinium DTPA Dimeglumine Salt, Dimeglumine, Gadopentetate, Meglumine gadopentetate 
A gadolinium complex of diethylenetriamine pentaacetic acid with ionic paramagnetic properties. Gadopentetate dimeglumine may provide contrast… 
National Institutes of Health

Related topics

Related topics

8 relations
Drug Allergygadopentetate

Broader (5)

Drug CombinationsGadolinium DTPAMeglumineOrganometallic Compounds

Narrower (1)

Magnevist

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.
OBJECTIVE The objective of this study was to evaluate signal changes in the dentate nucleus on unenhanced T1-weighted MR images… 
Review
2013
Review
2013
Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.
PURPOSE To determine whether acute transient dyspnea and/or arterial phase image degradation occurs more or less often after… 
Review
2009
Review
2009
In vivo MRI cell tracking: clinical studies.
  • J. Bulte
  • AJR. American journal of roentgenology
  • 2009
  • Corpus ID: 31115794
OBJECTIVE The purpose of this review is to describe the principles of MRI cell tracking with superparamagnetic iron oxides and… 
Review
2006
Review
2006
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Recently, it has been reported [1, 2] that a serious adverse reaction called nephrogenic systemic fibrosis (NSF) may occur after… 
Highly Cited
2004
Highly Cited
2004
Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy.
PURPOSE To prospectively evaluate static and dynamic gadopentetate dimeglumine-enhanced magnetic resonance (MR) imaging relative… 
Highly Cited
2000
Highly Cited
2000
Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis— cellularity correlates with the degree of enhancement…
OBJECTIVE Sacroiliitis is a hallmark of the spondyloarthropathies (SpA). The degree of inflammation can be quantified by magnetic… 
Highly Cited
1993
Highly Cited
1993
Enhancement of joint fluid with intravenously administered gadopentetate dimeglumine: technique, rationale, and implications.
This study reports findings on joint fluid enhancement after intravenous administration of gadopentetate dimeglumine. Ten… 
Highly Cited
1993
Highly Cited
1993
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions
It is now well established that clinically stable patients with relapsing–remitting multiple sclerosis have ongoing disease… 
Review
1992
Review
1992
MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review.
Findings on cranial magnetic resonance (MR) images were correlated with known histopathologic findings in 42 patients with… 
Highly Cited
1990
Highly Cited
1990
Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
Gadopentetate dimeglumine is an intravenous contrast medium used in magnetic resonance imaging. To determine its safety, the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)